Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 7/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | F10 | P00742 | 1/20 | 0.47 |
| ▸ | PLG | P00747 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.47 |
| ▸ | PLAT | P00750 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MPO | P05164 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL184146 | 0.88 | ALDH1A1 (0.44) | LMNATSHRHPGDKDM4EHSD17B10 | |
| SCHEMBL6438478 | 0.87 | LMNA (0.60) | LMNATSHRHPGDKDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL28090977 | 0.86 | ALDH1A1 (0.42) | LMNATSHRHPGDKDM4EHSD17B10 | |
| SCHEMBL28013496 | 0.85 | LMNA (0.58) | LMNATSHRHPGDKDM4EHSD17B10 | |
| SCHEMBL27908807 | 0.81 | TSHR (0.63) | LMNATSHRHPGDKDM4EHSD17B10 | |
| SCHEMBL10667678 | 0.81 | ALDH1A1 (0.61) | TSHRHPGDKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL6909900 | 0.81 | TSHR (0.53) | LMNATSHRHPGDKDM4EHSD17B10 | |
| Methyl Salicylate SCHEMBL27460362 | 0.81 | TSHR (0.73) | LMNATSHRHPGDKDM4EHSD17B10 | |
| SCHEMBL10501149 | 0.80 | LMNA (0.67) | LMNATSHRHPGDKDM4EHSD17B10 | |
| SCHEMBL6912975 | 0.80 | TSHR (0.56) | LMNATSHRHPGDKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090004128-A1 | Non-Irritant Rapid-Action Dipilatory Composition | PRODUCCIONES INFOVISION (MX) | 2009-01-01 | — | — | US | claimed |
| US-12491493-B1 | Amine appended bimetallic metal-organic framework (MOF-74) for carbon dioxide capture and method of preparation thereof | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-12-09 | — | — | US | disclosed |
| EP-4088784-A1 | COMPOSITION FOR DISINFECTION AND COSMETIC APPLICATIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2022-11-16 | — | — | EP | disclosed |
| US-9150504-B2 | Fatty acid guanidine and salicylate guanidine derivatives and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-9150504-B2 | Fatty acid guanidine and salicylate guanidine derivatives and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-9150504-B2 | Fatty acid guanidine and salicylate guanidine derivatives and their uses | CATABASIS PHARMACEUTICALS, INC. (US) | 2015-10-06 | — | — | US | disclosed |
| EP-2701509-A4 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS INC (US) | 2015-06-17 | — | — | EP | disclosed |
| CN-104262204-A | Preparation method of guanidine salicylate compound | JIANGSU TIANSHENG PHARMACEUTICAL CO LTD | 2015-01-07 | — | — | CN | disclosed |
| CN-104262204-A | Preparation method of guanidine salicylate compound | JIANGSU TIANSHENG PHARMACEUTICAL CO LTD | 2015-01-07 | — | — | CN | disclosed |
| EP-2701509-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | Catabasis Pharmaceuticals, Inc. (US) | 2014-03-05 | — | — | EP | disclosed |
| EP-2701509-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | Catabasis Pharmaceuticals, Inc. (US) | 2014-03-05 | — | — | EP | disclosed |
| EP-2701509-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | Catabasis Pharmaceuticals, Inc. (US) | 2014-03-05 | — | — | EP | disclosed |
| WO-2012149352-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012149352-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012149352-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| US-20120277305-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120277305-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-20120277305-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | CATABASIS PHARMACEUTICALS, INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-20090004128-A1 | Non-Irritant Rapid-Action Dipilatory Composition | PRODUCCIONES INFOVISION (MX) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120277305-A1 | FATTY ACID GUANIDINE AND SALICYLATE GUANIDINE DERIVATIVES AND THEIR USES | SCD, SCD5, FASN | LMNA 812/4885TSHR 3580/4885HPGD 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.